Vaccine News and Research

Latest Vaccine News and Research

COVID-19 misinformation spread on social media by US physicians

The harm caused by coronavirus disease 2019 (COVID-19) misinformation.

18 Aug 2023

Immune cells present in people months before influenza infection, finds study

St. Jude Children's Research Hospital scientists, in collaboration with the Institute of Environmental Science and Research (ESR) Limited, found that immune cells present in people months before influenza (flu) infection could more accurately predict if an individual would develop symptoms than current methods which primarily rely on antibody levels.

18 Aug 2023

New method to assess the status of immune responses to specific antigens in detail

A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire has been developed by a research group, consisting of Assistant Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, Professor Hironobu Minami (Kobe University Graduate School of Medicine), Associate Professor Goh Ohji (Kobe University Hospital), and Researcher Takaji Matsutani (Repertoire Genesis Inc.).

18 Aug 2023

Current methods overestimate malaria parasite multiplication rates

Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person's blood, which has important implications for determining how harmful they could be to a host, according to a new report.

17 Aug 2023

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Researchers evaluated distinct immune responses to mRNA and vector-based COVID-19 vaccines and natural SARS-CoV-2 infections.

17 Aug 2023

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Researchers report that convalescent plasma treatment is most effective in treating hospitalized COVID-19 patients.

17 Aug 2023

Prior vaccinations may help protect against Alzheimer's disease

Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer's disease, according to new research from UTHealth Houston.

16 Aug 2023

Bioengineered nanovesicles could improve cancer treatment

Nanovesicles can be bioengineered to target cancer cells and deliver treatments directly, according to research at Binghamton University, State University of New York.

16 Aug 2023

Most infants admitted to ICU for RSV were previously healthy, study finds

Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.

16 Aug 2023

Study evaluates differences in humoral immune response against SARS-CoV-2 in infants versus mothers

Researchers comparatively evaluated humoral immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among infants and their mothers.

16 Aug 2023

Evolutionary roadmap revealed: How SARS-CoV-2 adapted and evolved over three years

The evolutionary trends of amino acid alterations at a population scale.

16 Aug 2023

CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system

A gamified tool to estimate infection risks associated with day-to-day activities during the COVID-19 pandemic.

16 Aug 2023

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with other collaborating groups, have discovered the first lipid vascular 'ZIP code' in the lungs.

16 Aug 2023

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Researchers presented a scalable lipid nanoparticle production (SCALAR) platform to develop SARS-CoV-2 mRNA lipid nanoparticle vaccines.

15 Aug 2023

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

The history of using human challenge trials in developing vaccines.

15 Aug 2023

Investigating the potential differences in waning of post-vaccination neutralizing antibody titers

The decline patterns of neutralizing antibodies following coronavirus disease 2019 (COVID-19) vaccination.

15 Aug 2023

UAB researchers identify cell-surface marker that indicates fate of T cells

Follicular helper T cells, or Tfh cells, have a crucial role in immune defense. Without Tfh cells, B cells cannot form germinal center, or GC, responses during which high-affinity antibodies are generated.

14 Aug 2023

Most people in Canada now have hybrid immunity against COVID-19

Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.

14 Aug 2023

The protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection

Researchers estimate the protective effect of hybrid immunity on infection with the SARS-CoV-2 Omicron variant.

14 Aug 2023

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Scientists have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against EBV in mice.

14 Aug 2023

Previous
1
...
61
62
63
64
65
66
67
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

COVID-19 misinformation spread on social media by US physicians

Immune cells present in people months before influenza infection, finds study

New method to assess the status of immune responses to specific antigens in detail

Current methods overestimate malaria parasite multiplication rates

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Prior vaccinations may help protect against Alzheimer's disease

Bioengineered nanovesicles could improve cancer treatment

Most infants admitted to ICU for RSV were previously healthy, study finds

Study evaluates differences in humoral immune response against SARS-CoV-2 in infants versus mothers

Evolutionary roadmap revealed: How SARS-CoV-2 adapted and evolved over three years

CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Researchers develop platform allowing mass-scale production of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

Investigating the potential differences in waning of post-vaccination neutralizing antibody titers

UAB researchers identify cell-surface marker that indicates fate of T cells

Most people in Canada now have hybrid immunity against COVID-19

The protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in